Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.
Purity:
>95% Determined by SDS-PAGE
Target:
RSV
Application Dilute:
In Vivo Grade Recombinant Human IgG1 Kappa Isotype Control Antibody
Application Notes:
Applications: ELISA,neutralization,functional assays such as bioanalytical PK and ADA assays,and those assays for studying biological pathways. ResearchArea: Cancer immunology. Shipping: Ice Bag
* VAT and and shipping costs not included. Errors and price changes excepted
